Absence  ||| S:0 E:8 ||| NN
of  ||| S:8 E:11 ||| IN
peripheral  ||| S:11 E:22 ||| JJ
blood  ||| S:22 E:28 ||| NN
chimerism  ||| S:28 E:38 ||| NN
in  ||| S:38 E:41 ||| IN
graft-vs-host  ||| S:41 E:55 ||| JJ
disease  ||| S:55 E:63 ||| NN
following  ||| S:63 E:73 ||| VBG
orthotopic  ||| S:73 E:84 ||| JJ
liver  ||| S:84 E:90 ||| NN
transplantation ||| S:90 E:105 ||| NN
:  ||| S:105 E:107 ||| :
case  ||| S:107 E:112 ||| NN
report  ||| S:112 E:119 ||| NN
and  ||| S:119 E:123 ||| CC
review  ||| S:123 E:130 ||| NN
of  ||| S:130 E:133 ||| IN
the  ||| S:133 E:137 ||| DT
literature  ||| S:137 E:148 ||| NN
Graft-vs-host  ||| S:148 E:162 ||| JJ
disease  ||| S:162 E:170 ||| NN
( ||| S:170 E:171 ||| -LRB-
GVHD ||| S:171 E:175 ||| NNP
)  ||| S:175 E:177 ||| -RRB-
is  ||| S:177 E:180 ||| VBZ
a  ||| S:180 E:182 ||| DT
rare  ||| S:182 E:187 ||| JJ
and  ||| S:187 E:191 ||| CC
often  ||| S:191 E:197 ||| RB
fatal  ||| S:197 E:203 ||| JJ
complication  ||| S:203 E:216 ||| NN
of  ||| S:216 E:219 ||| IN
orthotopic  ||| S:219 E:230 ||| FW
liver  ||| S:230 E:236 ||| FW
transplantation  ||| S:236 E:252 ||| FW
( ||| S:252 E:253 ||| -LRB-
OLT ||| S:253 E:256 ||| NNP
) ||| S:256 E:257 ||| -RRB-
.  ||| S:257 E:259 ||| .
The  ||| S:259 E:263 ||| DT
skin  ||| S:263 E:268 ||| NN
is  ||| S:268 E:271 ||| VBZ
frequently  ||| S:271 E:282 ||| RB
involved  ||| S:282 E:291 ||| VBN
early  ||| S:291 E:297 ||| RB
in  ||| S:297 E:300 ||| IN
disease  ||| S:300 E:308 ||| NN
progression ||| S:308 E:319 ||| NN
,  ||| S:319 E:321 ||| ,
but  ||| S:321 E:325 ||| CC
clinical  ||| S:325 E:334 ||| JJ
and  ||| S:334 E:338 ||| CC
histopathological  ||| S:338 E:356 ||| JJ
features  ||| S:356 E:365 ||| NNS
may  ||| S:365 E:369 ||| MD
be  ||| S:369 E:372 ||| VB
nonspecific ||| S:372 E:383 ||| NNS
,  ||| S:383 E:385 ||| ,
presenting  ||| S:385 E:396 ||| VBG
a  ||| S:396 E:398 ||| DT
diagnostic  ||| S:398 E:409 ||| JJ
challenge ||| S:409 E:418 ||| NN
.  ||| S:418 E:420 ||| .
While  ||| S:420 E:426 ||| IN
the  ||| S:426 E:430 ||| DT
detection  ||| S:430 E:440 ||| NN
of  ||| S:440 E:443 ||| IN
peripheral  ||| S:443 E:454 ||| JJ
blood  ||| S:454 E:460 ||| NN
chimerism  ||| S:460 E:470 ||| NN
has  ||| S:470 E:474 ||| VBZ
been  ||| S:474 E:479 ||| VBN
proposed  ||| S:479 E:488 ||| VBN
as  ||| S:488 E:491 ||| IN
a  ||| S:491 E:493 ||| DT
diagnostic  ||| S:493 E:504 ||| JJ
criterion  ||| S:504 E:514 ||| NN
for  ||| S:514 E:518 ||| IN
post-OLT  ||| S:518 E:527 ||| NNP
GVHD ||| S:527 E:531 ||| NNP
,  ||| S:531 E:533 ||| ,
it  ||| S:533 E:536 ||| PRP
is  ||| S:536 E:539 ||| VBZ
not  ||| S:539 E:543 ||| RB
known  ||| S:543 E:549 ||| VBN
whether  ||| S:549 E:557 ||| IN
peripheral  ||| S:557 E:568 ||| JJ
blood  ||| S:568 E:574 ||| NN
chimerism  ||| S:574 E:584 ||| NN
is  ||| S:584 E:587 ||| VBZ
an  ||| S:587 E:590 ||| DT
absolute  ||| S:590 E:599 ||| JJ
requirement  ||| S:599 E:611 ||| NN
for  ||| S:611 E:615 ||| IN
the  ||| S:615 E:619 ||| DT
diagnosis ||| S:619 E:628 ||| NN
.  ||| S:628 E:630 ||| .
We  ||| S:630 E:633 ||| PRP
report  ||| S:633 E:640 ||| VBP
a  ||| S:640 E:642 ||| DT
case  ||| S:642 E:647 ||| NN
of  ||| S:647 E:650 ||| IN
a  ||| S:650 E:652 ||| DT
57-year-old  ||| S:652 E:664 ||| JJ
man  ||| S:664 E:668 ||| NN
who  ||| S:668 E:672 ||| WP
developed  ||| S:672 E:682 ||| VBD
post-OLT  ||| S:682 E:691 ||| JJ
GVHD  ||| S:691 E:696 ||| NN
with  ||| S:696 E:701 ||| IN
cutaneous ||| S:701 E:710 ||| NN
,  ||| S:710 E:712 ||| ,
enteric ||| S:712 E:719 ||| NN
,  ||| S:719 E:721 ||| ,
and  ||| S:721 E:725 ||| CC
bone  ||| S:725 E:730 ||| JJ
marrow  ||| S:730 E:737 ||| JJ
involvement ||| S:737 E:748 ||| NN
.  ||| S:748 E:750 ||| .
We  ||| S:750 E:753 ||| PRP
also  ||| S:753 E:758 ||| RB
review  ||| S:758 E:765 ||| VB
the  ||| S:765 E:769 ||| DT
epidemiology ||| S:769 E:781 ||| NN
,  ||| S:781 E:783 ||| ,
pathogenesis ||| S:783 E:795 ||| NN
,  ||| S:795 E:797 ||| ,
clinical  ||| S:797 E:806 ||| JJ
presentation ||| S:806 E:818 ||| NN
,  ||| S:818 E:820 ||| ,
histopathology ||| S:820 E:834 ||| NN
,  ||| S:834 E:836 ||| ,
molecular  ||| S:836 E:846 ||| JJ
diagnostic  ||| S:846 E:857 ||| JJ
techniques ||| S:857 E:867 ||| NNS
,  ||| S:867 E:869 ||| ,
and  ||| S:869 E:873 ||| CC
treatment  ||| S:873 E:883 ||| NN
of  ||| S:883 E:886 ||| IN
GVHD  ||| S:886 E:891 ||| NNP
following  ||| S:891 E:901 ||| VBG
liver  ||| S:901 E:907 ||| JJ
transplantation ||| S:907 E:922 ||| NN
.  ||| S:922 E:924 ||| .
In  ||| S:924 E:927 ||| IN
our  ||| S:927 E:931 ||| PRP$
patient ||| S:931 E:938 ||| NN
,  ||| S:938 E:940 ||| ,
analysis  ||| S:940 E:949 ||| NN
of  ||| S:949 E:952 ||| IN
the  ||| S:952 E:956 ||| DT
peripheral  ||| S:956 E:967 ||| JJ
blood  ||| S:967 E:973 ||| NN
by  ||| S:973 E:976 ||| IN
short-tandem  ||| S:976 E:989 ||| JJ
repeat  ||| S:989 E:996 ||| NN
polymerase  ||| S:996 E:1007 ||| NN
chain  ||| S:1007 E:1013 ||| NN
reaction  ||| S:1013 E:1022 ||| NN
did  ||| S:1022 E:1026 ||| VBD
not  ||| S:1026 E:1030 ||| RB
detect  ||| S:1030 E:1037 ||| VB
circulating  ||| S:1037 E:1049 ||| VBG
donor  ||| S:1049 E:1055 ||| NN
lymphocytes ||| S:1055 E:1066 ||| NN
.  ||| S:1066 E:1068 ||| .
Donor  ||| S:1068 E:1074 ||| JJ
lymphocytes  ||| S:1074 E:1086 ||| NN
were  ||| S:1086 E:1091 ||| VBD
detected  ||| S:1091 E:1100 ||| VBN
in  ||| S:1100 E:1103 ||| IN
the  ||| S:1103 E:1107 ||| DT
buccal  ||| S:1107 E:1114 ||| JJ
mucosa ||| S:1114 E:1120 ||| NN
,  ||| S:1120 E:1122 ||| ,
however ||| S:1122 E:1129 ||| RB
,  ||| S:1129 E:1131 ||| ,
confirming  ||| S:1131 E:1142 ||| VBG
the  ||| S:1142 E:1146 ||| DT
diagnosis ||| S:1146 E:1155 ||| NN
.  ||| S:1155 E:1157 ||| .
A  ||| S:1157 E:1159 ||| DT
review  ||| S:1159 E:1166 ||| NN
of  ||| S:1166 E:1169 ||| IN
chimerism  ||| S:1169 E:1179 ||| JJ
patterns  ||| S:1179 E:1188 ||| NNS
in  ||| S:1188 E:1191 ||| IN
63  ||| S:1191 E:1194 ||| CD
previously  ||| S:1194 E:1205 ||| RB
published  ||| S:1205 E:1215 ||| VBN
cases  ||| S:1215 E:1221 ||| NNS
of  ||| S:1221 E:1224 ||| IN
post-OLT  ||| S:1224 E:1233 ||| NNP
GVHD  ||| S:1233 E:1238 ||| NNP
reveals  ||| S:1238 E:1246 ||| VBZ
that  ||| S:1246 E:1251 ||| IN
this  ||| S:1251 E:1256 ||| DT
is  ||| S:1256 E:1259 ||| VBZ
the  ||| S:1259 E:1263 ||| DT
first  ||| S:1263 E:1269 ||| JJ
reported  ||| S:1269 E:1278 ||| JJ
case  ||| S:1278 E:1283 ||| NN
in  ||| S:1283 E:1286 ||| IN
which  ||| S:1286 E:1292 ||| WDT
chimerism  ||| S:1292 E:1302 ||| NNS
was  ||| S:1302 E:1306 ||| VBD
absent  ||| S:1306 E:1313 ||| VBN
in  ||| S:1313 E:1316 ||| IN
the  ||| S:1316 E:1320 ||| DT
peripheral  ||| S:1320 E:1331 ||| JJ
blood  ||| S:1331 E:1337 ||| NN
but  ||| S:1337 E:1341 ||| CC
present  ||| S:1341 E:1349 ||| JJ
in  ||| S:1349 E:1352 ||| IN
another  ||| S:1352 E:1360 ||| DT
site ||| S:1360 E:1364 ||| NN
.  ||| S:1364 E:1366 ||| .
Peripheral  ||| S:1366 E:1377 ||| JJ
blood  ||| S:1377 E:1383 ||| NN
chimerism  ||| S:1383 E:1393 ||| NNS
may  ||| S:1393 E:1397 ||| MD
be  ||| S:1397 E:1400 ||| VB
absent  ||| S:1400 E:1407 ||| VBN
in  ||| S:1407 E:1410 ||| IN
cases  ||| S:1410 E:1416 ||| NNS
of  ||| S:1416 E:1419 ||| IN
post-OLT  ||| S:1419 E:1428 ||| NNP
GVHD ||| S:1428 E:1432 ||| NNP
.  ||| S:1432 E:1434 ||| .
A  ||| S:1434 E:1436 ||| DT
combination  ||| S:1436 E:1448 ||| NN
of  ||| S:1448 E:1451 ||| IN
clinical ||| S:1451 E:1459 ||| JJ
,  ||| S:1459 E:1461 ||| ,
histopathological ||| S:1461 E:1478 ||| NN
,  ||| S:1478 E:1480 ||| ,
and  ||| S:1480 E:1484 ||| CC
molecular  ||| S:1484 E:1494 ||| JJ
features  ||| S:1494 E:1503 ||| NNS
is  ||| S:1503 E:1506 ||| VBZ
therefore  ||| S:1506 E:1516 ||| RB
required  ||| S:1516 E:1525 ||| VBN
to  ||| S:1525 E:1528 ||| TO
make  ||| S:1528 E:1533 ||| VB
this  ||| S:1533 E:1538 ||| DT
challenging  ||| S:1538 E:1550 ||| JJ
diagnosis ||| S:1550 E:1559 ||| NN
.  ||| S:1559 E:1561 ||| .
